Modulation of mitochondrial biogenesis by the Integrated Stress Response (ISR)
Project Number1F30AG077833-01
Contact PI/Project LeaderKIM, SOOKYUNG
Awardee OrganizationUNIV OF MASSACHUSETTS MED SCH WORCESTER
Description
Abstract Text
Project Summary
Mitochondrial function declines during aging. The dysfunction is accelerated in age-associated diseases such
as Alzheimer’s Disease and Parkinson’s Disease. Thus, therapeutic approaches to maintain or recover
mitochondrial function may promote healthy aging or slow age-associated disease progression. Recently, we
have shown that the mitochondrial network expansion that occurs during development is an emergent property
of the synthesis of highly expressed mitochondrial proteins. Increased mitochondrial import of the highly
expressed mitochondrial proteins outcompete the transcription factor ATFS-1, preventing it from entering
mitochondria. This allows ATFS-1 to traffic to the nucleus and activate a mitochondrial network expansion
transcription program known as UPRmt. These findings suggest an interplay between protein synthesis,
mitochondria protein import capacity, and mitochondrial network expansion.
The Integrated Stress Response (ISR) is a translation control pathway that reduces overall protein
synthesis while preferentially increases translation of ATF-4 in response to diverse stressors including amino
acid depletion, ER dysfunction and mitochondrial perturbations. The ISR is mediated by 4 kinases (3 in C.
elegans) that all phosphorylate the translation initiation factor eIF2α, which in turn modulates protein synthesis.
While considerable work has demonstrated that the ISR is active in response to mitochondrial perturbation, the
functional outputs of the ISR related to mitochondrial biology remain unknown. I have obtained or generated
several C. elegans strains in which the ISR is impaired. Quite surprisingly, these worms have increased
mitochondrial mass and mitochondrial genomes. Intriguingly, these animals also live significantly longer than
wildtype worms, suggesting that increased mitochondrial mass is sufficient to extend organismal lifespan. I
hypothesize that the ISR matches mitochondrial network expansion with the physiological and environmental
inputs that activate the ISR by antagonizing ATFS-1 function. Here, I focus on the role of ISR-dependent
translation attenuation or ATF-4 synthesis as direct or indirect regulators of ATFS-1-dependent transcription via
the following aims.
1. Determine the mechanisms by which the ISR regulates ATFS-1-dependent mitochondrial biogenesis.
2. Elucidate the mechanisms by which the ISR modulates longevity and healthspan.
Public Health Relevance Statement
Project Narrative
A decline in mitochondrial function occurs during aging, which is accelerated in age-associated diseases such
as Alzheimer’s Disease and Parkinson’s Disease. Thus, understanding how cells establish a mitochondrial
network during development and adjust that network throughout a cell’s lifetime to meet physiological needs is
a necessary step to develop therapies that treat mitochondrial dysfunction and associated diseases. Here, we
aim to understand the mechanisms by which the Integrated Stress Response regulates mitochondrial expansion
and stress signaling to promote healthy aging.
No Sub Projects information available for 1F30AG077833-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1F30AG077833-01
Patents
No Patents information available for 1F30AG077833-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1F30AG077833-01
Clinical Studies
No Clinical Studies information available for 1F30AG077833-01
News and More
Related News Releases
No news release information available for 1F30AG077833-01
History
No Historical information available for 1F30AG077833-01
Similar Projects
No Similar Projects information available for 1F30AG077833-01